Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
3(15%)
Results Posted
10%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_4
1
5%
Ph not_applicable
10
50%
Ph phase_1
5
25%
Ph phase_2
4
20%

Phase Distribution

5

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
5(25.0%)
Phase 2Efficacy & side effects
4(20.0%)
Phase 4Post-market surveillance
1(5.0%)
N/ANon-phased studies
10(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

20

all time

Status Distribution
Active(4)
Completed(10)
Terminated(1)
Other(5)

Detailed Status

Completed10
unknown5
Recruiting2
Terminated1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
3
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (25.0%)
Phase 24 (20.0%)
Phase 41 (5.0%)
N/A10 (50.0%)

Trials by Status

terminated15%
unknown525%
completed1050%
not_yet_recruiting15%
recruiting210%
active_not_recruiting15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07567742Phase 2

Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma

Not Yet Recruiting
NCT06721949Phase 2

Taurine Supplementation in Long COVID

Recruiting
NCT07466654Not Applicable

Low-Dose Caffeine and Taurine Effects on Performance

Completed
NCT06128252Not Applicable

Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer

Recruiting
NCT06639711Phase 1

Taurine Eye Drops May Prevent the Progression of Cataract

Active Not Recruiting
NCT06123455Phase 2

Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer

Unknown
NCT04291352Not Applicable

Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation

Unknown
NCT05149716Not Applicable

Taurine as a Possible Anti-aging Therapy?

Completed
NCT04772508Not Applicable

Effect of Amnion Membrane With and Without Taurine on GCF TNF α Level.

Completed
NCT04279600Not Applicable

Taurine Supplementation and Training Effects on Energy Metabolism, Inflammation and Oxidative Stress in Obese Women

Completed
NCT04192539Not Applicable

The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers

Completed
NCT00217165Phase 2

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

Completed
NCT01192828Phase 1

Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine

Completed
NCT01381354Phase 1

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Completed
NCT03410537Not Applicable

Taurine Supplementation on Lower Extremity Vasculopathy in Patients With Diabetes

Unknown
NCT03410173Not Applicable

Taurine Supplementation on Cognitive Function in Patients With Diabetes

Unknown
NCT02535143Phase 4

Impact of Energy Drinks on the Manual Dexterity of Final Year Dental Students

Completed
NCT01226537Phase 1

Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients

Unknown
NCT00497978Not Applicable

The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient

Completed
NCT00391001Phase 1

Taurine in Adolescents With Bipolar Disorder

Terminated

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20